Two special EARL Symposia at EANM’26

Join the two special EARL Symposia at EANM’26!

Published: September 22, 2026

Discover how EARL is advancing standardisation, harmonisation and reproducibility in quantitative nuclear medicine at two dedicated symposia during EANM’26.

1. Special Symposium 2 – EARL: Clinical Implications of EARL PET/CT Accreditation Standards 3, 177 Lu SPECT/CT Accreditation for Nal and CZT: Results, Specifications, and Future Directions

Sunday, October 18 | 09:45–11:15 | Hall D – Arena

Standardisation is key to confidence in quantitative imaging.

Explore how EARL is advancing harmonisation and reproducibility through PET/CT and ¹⁷⁷Lu SPECT/CT accreditation, and how robust imaging performance, standardised procedures and quantitative biomarkers can support:

• More reliable diagnosis and response assessment
• Personalised dosimetry in radionuclide therapy
• Reproducible multicentre research
• Ultimately, better patient care

Join the discussion on where accreditation stands today and where quantitative nuclear medicine is heading next.

2. Special Symposium 4 – EARL: Unlock precision in imaging. Discover the clinical benefits of the EARL PET accreditations

Monday, October 19 | 09:45–11:15 | Hall G1

Can we trust quantitative PET measurements across different scanners?

Explore how EARL accreditations support reproducible quantitative PET imaging through standardisation and harmonisation, with topics including:

• Centiloids and EARL Brain
• TMTV, MTV and TLG for tumour burden
• Inter-scanner variability
• PSMA PET and SUV thresholds
• Multicentre and longitudinal studies

Harmonised imaging → reproducible biomarkers → greater clinical confidence.

Discover how quantitative PET harmonisation is helping move imaging towards precision medicine and better patient care.

For further details, don’t hesitate to check out the EANM’26 final programme.